Loading live market data…

Ligand Pharmaceuticals Incorporated

NASDAQ:LGND

$300.97 USD

-$8.28 (-2.68%)

Volume
649.08K
Average Volume
331.69K
Market Capitalization
$6.03B
P/E Ratio
38.39
Dividend Yield
0.00%
Price Target
$289.00
Year High
$326.63
Year Low
$122.29
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$21.28

LGND Estimated and Actual Revenue by Quarter

LGND Estimated and Actual EPS by Quarter

LGND Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 46.73M 60.07M 52.67M 28.85M 37.08M 32.51M
2027-09-30 3 44.03M 56.6M 49.62M 27.18M 34.94M 30.63M
2027-06-30 3 40.87M 52.54M 46.06M 25.23M 32.43M 28.43M
2027-03-31 3 36.71M 47.19M 41.37M 22.66M 29.13M 25.54M
2026-12-31 5 45.83M 58.92M 51.65M 28.29M 36.37M 31.89M
2026-09-30 6 39.98M 50.21M 44.18M 24.68M 30.99M 27.27M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 53.96M 74.79M 63.23M 30.2M 38.83M 34.04M
2027-09-30 3 50.06M 69.38M 58.65M 28.46M 36.58M 32.07M
2027-06-30 3 44.97M 62.32M 52.69M 26.41M 33.96M 29.77M
2027-03-31 3 39.03M 54.09M 45.73M 23.72M 30.5M 26.74M
2026-12-31 5 49.72M 68.91M 58.26M 29.62M 38.08M 33.38M
2026-09-30 6 47.41M 56.19M 50.53M 25.84M 32.45M 28.55M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 85.4M 109.79M 96.26M 1 2.71394 3.76128 3.18
2027-09-30 3 80.47M 103.45M 90.7M 1 2.51765 3.48924 2.95
2027-06-30 3 74.69M 96.02M 84.18M 1 2.26162 3.1344 2.65
2027-03-31 3 67.09M 86.24M 75.61M 1 1.96291 2.72043 2.3
2026-12-31 5 83.76M 107.68M 94.4M 1 2.50058 3.46559 2.93
2026-09-30 6 73.07M 91.76M 80.74M 5 2.38426 2.82579 2.54125